Phosphomonoester and Breast Cancer Proliferation
Author Information
Author(s): R. Kalra, K.E. Wade, L. Hands, P. Styles, R. Camplejohn, M. Greenall, G.E. Adams, A.L. Harris, G.K. Radda
Primary Institution: MRC Radiobiology Unit, Chilton, Oxon, UK
Hypothesis
The study aims to assess the relationship between the level of phosphomonoester (PME) measured by 31P MRS in vivo and proliferation in untreated, primary human breast cancer.
Conclusion
The study found a significant association between the relative level of PME to ATP and proliferation for aneuploid tumours.
Supporting Evidence
- 39% of the tumours were diploid and 61% were aneuploid.
- The median S phase fraction for aneuploid tumours was significantly higher than for diploid tumours.
- There was a significant correlation between PME/ATP and S phase fraction for aneuploid tumours.
Takeaway
This study looked at how a specific chemical in breast cancer cells relates to how fast those cells are growing. They found that higher levels of this chemical are linked to faster-growing cancer cells.
Methodology
The study used 31P magnetic resonance spectroscopy (MRS) to measure phospholipid metabolism in breast cancer patients before surgery.
Limitations
The study had limitations in signal-to-noise ratio and spatial resolution, which affected the analysis of some tumours.
Participant Demographics
The median age of participants was 55 years, with a range from 35 to 71 years, and included both pre-menopausal and post-menopausal women.
Statistical Information
P-Value
0.007
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website